Clinicians have used feticidal agents prior to second trimester abortion for many years.
Despite the widespread use of various agents to induce fetal demise, a comprehensive or …

Objective To conduct an audit of the practice of feticide in second‐and third‐trimester
termination of pregnancy for fetal anomalies (TOPFA) in prenatal diagnosis (PD) centers in …

Objectives Mifepristone became available in Canada in 2017. Updated national guidelines
recommend its off-label use for second/third-trimester medical abortion (STMA/TTMA) by …

Feticide is the practice of inducing fetal demise before the termination of pregnancy. In
England and Wales, it is recommended for terminations of pregnancy beyond 21+ 6 weeks …

Background: Feticide was suggested to avoid delivering children with abnormalities.
Recently, twin pregnancies have increased. Selective feticide was proposed to achieve a …

Background Current literature recommends inducing fetal demise prior to second trimester
medication abortion beyond 20 weeks of gestation. There is inadequate literature regarding …

Background Transient fetal survival is one issue that providers may face while managing
late second-trimester abortion. Induction of fetal demise using digoxin and other means has …

Objective Our objective was to explore the workforce and clinical care of first and second-
trimester surgical abortion (FTSA, STSA) providers following the publication of the updated …

Objective This study sought to compare the efficacy and outcomes of fetal intracardiac
intraventricular and interventricular septal potassium chloride (KCl) injections during the …

Résumé La réalisation d'un geste d'arrêt de vie fœtale (GAF) dans le cadre d'une
interruption médicale de la grossesse (IMG) est nécessaire afin d'éviter une naissance …